Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Unveils Sales Force Plan: Reorganization Involves “Modest” Cuts

This article was originally published in The Pink Sheet Daily

Executive Summary

The plan will be “very disappointing to our competitors,” CEO McKinnell declares. Pfizer will restructure sales force to reduce number of reps calling on individual doctors, but will not use layoffs to cut headcount significantly.

You may also be interested in...



Wyeth To Begin Primary Care Sales Force Reorganization In July

The company is shifting some of its 2,500 U.S.-based primary care reps to part-time work. The move will reduce the frequency of visits to physician offices and increase efficiency, Wyeth says. The reorganization is expected to be completed by year-end.

Wyeth To Begin Primary Care Sales Force Reorganization In July

The company is shifting some of its 2,500 U.S.-based primary care reps to part-time work. The move will reduce the frequency of visits to physician offices and increase efficiency, Wyeth says. The reorganization is expected to be completed by year-end.

No Merger Needed: Pfizer Efficiency Program To Generate $4 Bil. In Savings

Pfizer is launching a productivity initiative to generate $4 bil. in annual cost savings by 2008, the company announced during its New York City analyst meeting April 5

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel